Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Digestive and Liver Disease

• Publication date

  2017-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.dld.2017.08.002PMID 28869158
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multicenter External Validation of Risk Stratification Criteria for Patients With Variceal Bleeding

  2018cited by this paper
• Beta adrenergic blockade and decompensated cirrhosis.

  2017cited by this paper
• Emergency TIPS in a Child-Pugh B patient: When does the window of opportunity open and close?

  2017cited by this paper
• Beta blockers and cirrhosis, 2016.

  2017cited by this paper
• Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension

  2015cited by this paper
• Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.

  2015cited by this paper
• Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites

  2015cited by this paper
• Early‐TIPSS placement prevents rebleeding in high‐risk patients with variceal bleeding, without improving survival

  2014cited by this paper
• Prediction of early mortality after variceal bleeding: score one more for MELD.

  2014cited by this paper
• Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.

  2013cited by this paper
• Economic modelling of early transjugular intrahepatic portosystemic shunt insertion for acute variceal haemorrhage

  2013cited by this paper
• Randomized Controlled Trial of Emergency Transjugular Intrahepatic Portosystemic Shunt Versus Emergency Portacaval Shunt Treatment of Acute Bleeding Esophageal Varices in Cirrhosis

  2012cited by this paper
• Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol

  2012cited by this paper
• Noninvasive screening for liver fibrosis and portal hypertension by transient elastography—a large single center experience

  2012cited by this paper
• Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study.

  2012cited by this paper
• Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS.

  2011cited by this paper
• Early TIPS with covered stents in high-risk patients with cirrhosis presenting with variceal bleeding: are we ready to dive into the deep end of the pool?

  2011cited by this paper
• Deleterious effects of beta‐blockers on survival in patients with cirrhosis and refractory ascites

  2010cited by this paper
• Early use of TIPS in patients with cirrhosis and variceal bleeding.

  2010cited by this paper
• Hyponatremia and mortality among patients on the liver-transplant waiting list.

  2008cited by this paper
• Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis

  2007cited by this paper
• Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis

  2007cited by this paper
• Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data.

  2007cited by this paper
• The model for end‐stage liver disease (MELD)

  2007cited by this paper
• Evidence-based incorporation of serum sodium concentration into MELD.

  2006cited by this paper
• Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension.

  2005cited by this paper
• Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension.

  2005cited by this paper
• Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death

  2004cited by this paper
• Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study.

  2004cited by this paper
• Humoral and cardiac effects of TIPS in cirrhotic patients with different “effective” blood volume

  2003cited by this paper
• ePTFE-Covered Stent-Grafts for Revision of Obstructed Transjugular Intrahepatic Portosystemic Shunt

  2002cited by this paper
• A Proportional Hazards Model for the Subdistribution of a Competing Risk

  1999cited by this paper
• Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings.

  1998cited by this paper
• Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage.

  1990cited by this paper
• A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

  1988cited by this paper

• EASL Clinical Practice Guidelines on TIPS.

  2025cites this paper
• Alcohol Use After TIPS Implantation Significantly Increases the Risk of ACLF and Liver‐Related Death

  2025cites this paper
• Effectiveness of controlled-expansion transjugular intrahepatic portosystemic shunt (CX-TIPS) in an interdisciplinary setting at a large tertiary center.

  2025cites this paper
• Clinical Trends and Hospital Mortality of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Germany: A Descriptive Analysis Between 2019 and 2023

  2025cites this paper
• Azygoportal disconnection or a combination of non-selective beta-blockers and endoscopic variceal ligation to prevent recurrent bleeding in patients with cirrhosis awaiting transplantation

  2024cites this paper
• Decreasing interleukin-6 levels after TIPS predict outcomes in decompensated cirrhosis

  2024cites this paper
• Portal Hypertensive Gastropathy and MELD‐Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study

  2024cites this paper
• Does encephalopathy with early onset after TIPS impact on mortality?

  2024cites this paper
• Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care

  2023cites this paper
• The clinical relevance of acute‐on‐chronic liver failure in medical procedures: Endoscopy, interventions and surgery

  2023cites this paper
• Use and outcome of TIPS in hospitalized patients in Germany: A Nationwide study (2007–2018)

  2023cites this paper
• EASL Clinical Practice Guidelines on acute-on-chronic liver failure.

  2023cites this paper
• To TIPS or Not to TIPS in High Risk of Variceal Rebleeding and Acute-on-Chronic Liver Failure

  2023cites this paper
• TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis.

  2023cites this paper
• Portal hypertension and variceal bleeding in patients with liver cancer: Evidence gaps for prevention and management

  2023cites this paper
• [Current Interventional Management of Acute Upper Gastrointestinal Bleeding].

  2022cites this paper
• Imaging-guided interventions modulating portal venous flow: Evidence and controversies

  2022cites this paper
• Effect of time to pre‐emptive transjugular intrahepatic portosystemic shunt on patient outcome, a UK multicentre cohort study

  2022cites this paper
• Editorial: how early should ‘early TIPSS’ be in cirrhosis with acute variceal bleeding?

  2022cites this paper
• Early transjugular intrahepatic portosystemic shunt for acute variceal bleeding: a systematic review and meta-analysis

  2021cites this paper
• Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis

  2021cites this paper
• North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension.

  2021cites this paper
• Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.

  2020cites this paper
• Where does TIPS fit in the management of patients with cirrhosis?

  2020cites this paper
• Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysis

  2020cites this paper
• Non‐invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease

  2020cites this paper
• Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS.

  2020cites this paper
• Emergent Transjugular Intrahepatic Portosystemic Shunt Creation in Acute Variceal Bleeding

  2020cites this paper
• Lower 90-day Hospital Readmission Rates for Esophageal Variceal Bleeding After TIPS

  2020cites this paper
• Futility criteria for preemptive TIPS in patients with cirrhosis and variceal bleeding are still missing in most severe patients!

  2020cites this paper
• Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria

  2020cites this paper
• Transjugular aspiration liver biopsy performed by hepatologists trained in HVPG measurements is safe and provides important diagnostic information.

  2019cites this paper
• Early-TIPS zur Blutungskontrolle bei portaler Hypertension findet selten Anwendung

  2018cites this paper
• Long-term shunt patency and overall survival of transjugular intrahepatic portosystemic shunt placement using covered stents with bare stents versus covered stents alone.

  2018cites this paper
• Early TIPS for portal hypertensive related bleeding: Is resource or education the reason for failure to show clear survival benefit?

  2017cites this paper